PET and SPECT Imaging in the SARS-CoV-2 Pandemic

Author(s): Laura Evangelista*, Pierpaolo Alongi, Orazio Schillaci

Journal Name: Current Radiopharmaceuticals

Volume 13 , Issue 2 , 2020


Become EABM
Become Reviewer
Call for Editor

[1]
Trotter, C.L.; Stuart, J.M.; George, R.; Miller, E. Increasing hospital admissions for pneumonia, England. Emerg. Infect. Dis., 2008, 14(5), 727-733.
[http://dx.doi.org/10.3201/eid1405.071011] [PMID: 18439353]
[2]
Xu, X.; Yu, C.; Qu, J.; Zhang, L.; Jiang, S.; Huang, D.; Chen, B.; Zhang, Z.; Guan, W.; Ling, Z.; Jiang, R.; Hu, T.; Ding, Y.; Lin, L.; Gan, Q.; Luo, L.; Tang, X.; Liu, J. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur. J. Nucl. Med. Mol. Imaging, 2020, 47(5), 1275-1280.
[http://dx.doi.org/10.1007/s00259-020-04735-9]] [PMID: 32107577]
[3]
Qin, C.; Liu, F.; Yen, T-C.; Lan, X. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur. J. Nucl. Med. Mol. Imaging, 2020, 47(5), 1281-1286.
[http://dx.doi.org/10.1007/s00259-020-04734-w] [PMID: 32088847]
[4]
Zou, S.; Zhu, X. FDG PET/CT of COVID-19. Radiology, 2020, 200770.
[http://dx.doi.org/10.1148/radiol.2020200770] [PMID: 32142399]
[5]
Giraudo, C.; Evangelista, L.; Fraia, A.S.; Lupi, A.; Quaia, E.; Cecchin, D.; Casali, M. Molecular Imaging of Pulmonary Inflammation and Infection. Int. J. Mol. Sci., 2020, 21(3)E894
[http://dx.doi.org/10.3390/ijms21030894] [PMID: 32019142]
[6]
Phillips, T.; Ferraz, I.; Bell, S.; Clegg, P.D.; Carter, S.D.; Mobasheri, A. Differential regulation of the GLUT1 and GLUT3 glucose transporters by growth factors and pro-inflammatory cytokines in equine articular chondrocytes. Vet. J., 2005, 169(2), 216-222.
[http://dx.doi.org/10.1016/j.tvjl.2004.01.026] [PMID: 15727913]
[7]
Paik, J-Y.; Lee, K-H.; Choe, Y.S.; Choi, Y.; Kim, B.T. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J. Nucl. Med., 2004, 45(1), 124-128.
[PMID: 14734684]
[8]
Mochizuki, T.; Tsukamoto, E.; Kuge, Y.; Kanegae, K.; Zhao, S.; Hikosaka, K.; Hosokawa, M.; Kohanawa, M.; Tamaki, N. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J. Nucl. Med., 2001, 42(10), 1551-1555.
[PMID: 11585872]
[9]
Chang, J.M.; Lee, H.J.; Goo, J.M.; Lee, H.Y.; Lee, J.J.; Chung, J.K.; Im, J.G. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J. Radiol., 2006, 7(1), 57-69.
[http://dx.doi.org/10.3348/kjr.2006.7.1.57] [PMID: 16549957]
[10]
Joob, B.; Wiwanitkit, V. 18F-FDG PET/CT and COVID-19. Eur. J. Nucl. Med. Mol. Imaging, 2020, 47(6), 1348.
[http://dx.doi.org/10.1007/s00259-020-04762-6]] [PMID: 32166511]
[11]
Albano, D.; Bertagna, F.; Bertoli, M.; Bosio, G.; Lucchini, S.; Motta, F.; Panarotto, M.B.; Peli, A.; Camoni, L.; Bengel, F.M.; Giubbini, R. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J. Nucl. Med., 2020, 61(5), 632-636.
[http://dx.doi.org/10.2967/jnumed.120.246256] [PMID: 32238429]
[12]
Polverari, G.; Arena, V.; Ceci, F. 18F-FDG uptake in Asymptomatic SARS-CoV-2 (COVID-19) patient, referred to PET/CT for Non-Small Cells Lung Cancer restaging. J. Thorac. Oncol., 2020. Epub ahead of print
[13]
Kirienko, M.; Padovano, B.; Serafini, G.; Marchianò, A.; Gronchi, A.; Seregni, E.; Alessi, A.C.T. [18F]FDG-PET/CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour. Eur. J. Nucl. Med. Mol. Imaging, 2020. Epub ahead of print
[http://dx.doi.org/10.1007/s00259-020-04822-x] [PMID: 32335706]
[14]
Pinker, K.; Riedl, C.; Weber, W.A. Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments. Eur. J. Nucl. Med. Mol. Imaging, 2017, 44(Suppl. 1), 55-66.
[http://dx.doi.org/10.1007/s00259-017-3687-3] [PMID: 28361188]
[15]
Nobashi, T.; Baratto, L.; Reddy, S.A.; Srinivas, S.; Toriihara, A.; Hatami, N.; Yohannan, T.K.; Mittra, E. Predicting response to immunotherapy by evaluating tumors, lymphoid cell-rich organs, and immune-related adverse events using FDG-PET/CT. Clin. Nucl. Med., 2019, 44(4), e272-e279.
[http://dx.doi.org/10.1097/RLU.0000000000002453] [PMID: 30688730]
[16]
Porfidia, A.; Pola, R. Venous thromboembolism in COVID-19 patients. J. Thromb. Haemost., 2020. Epub ahead of print
[http://dx.doi.org/10.1111/jth.14842] [PMID: 32294289]
[17]
Tang, N.; Bai, H.; Chen, X. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost., 2020. [Epub ahead of print]
[http://dx.doi.org/10.1111/jth.14817]
[18]
Huang, H.L.; Allie, R.; Gnanasegaran, G.; Bomanji, J. COVID19 -Nuclear medicine departments, be prepared! Nucl. Med. Commun., 2020, 41(4), 297-299.
[http://dx.doi.org/10.1097/MNM.0000000000001183] [PMID: 32168202]


free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 2
Year: 2020
Published on: 03 August, 2020
Page: [87 - 88]
Pages: 2
DOI: 10.2174/187447101302200622143626

Article Metrics

PDF: 28
HTML: 3
EPUB: 1
PRC: 1